AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders-Reference-Cited by-同舟云学术

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders

Published:2016-07-13 Issue:2 Volume:53 Page:583-620
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Ivachtchenko Alexandre V.¹²,Lavrovsky Yan³,Okun Ilya²

Affiliation:

1. Alla Chem LLC, Hallandale Beach, FL, USA

2. Avineuro Pharmaceuticals Inc., Hallandale Beach, FL, USA

3. R-Pharm Overseas, Inc., San Diego, CA, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference115 articles.

1. Chapter 6. Phenotypic and In Vivo Screening: Lead Discovery and Drug Repurposing

2. Simple drugs do not cure complex diseases: The need for multi-targeted drugs;Hornberg;Designing Multi-Target Drugs,2012

3. (2015) 2015 Alzheimer’s disease facts and figures. Alzheimers Dement 11, 332–384.

4. Anxiety and Depression Association of America. Facts & Statistics, http://www.adaa.org/about-adaa/press-room/facts-statistics, Last updated September, 2014.

5. Higher-end serotonin receptors: 5-HT 5, 5-HT 6, and 5-HT 7;Glennon;J Med Chem,2003

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of tetrahydro γ-carboline based novel glucose uptake agent for the treatment of diabetes and Alzheimer’s diseases;Results in Chemistry;2024-10

2. Aviandr is a new original drug for treating anxiety;Neurology, Neuropsychiatry, Psychosomatics;2024-08-22

3. Efficacy and safety of Aviandr in the treatment of anxiety in patients with adjustment disorders after COVID-19;S.S. Korsakov Journal of Neurology and Psychiatry;2024

4. Serotonin receptors - a potential target for the treatment of Alzheimer’s disease;Биохимия;2023-12-15

5. Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease;Biochemistry (Moscow);2023-12